APO-FLECAINIDE DIN 02275538
Health Canada record
| Active ingredient(s) | FLECAINIDE ACETATE 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01BC04 FLECAINIDE |
| Original market date | 08-May-2006 |
| Current status date | 15-Dec-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLECAINIDE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02516063 | AG-FLECAINIDE | ANGITA PHARMA INC. | Tablet | FLECAINIDE ACETATE 50 MG | Marketed |
| 02516071 | AG-FLECAINIDE | ANGITA PHARMA INC. | Tablet | FLECAINIDE ACETATE 100 MG | Marketed |
| 02275546 | APO-FLECAINIDE | APOTEX INC | Tablet | FLECAINIDE ACETATE 100 MG | Marketed |
| 02459957 | AURO-FLECAINIDE | AURO PHARMA INC | Tablet | FLECAINIDE ACETATE 50 MG | Marketed |
| 02459965 | AURO-FLECAINIDE | AURO PHARMA INC | Tablet | FLECAINIDE ACETATE 100 MG | Marketed |
| 02534819 | FLECAINIDE | SANIS HEALTH INC | Tablet | FLECAINIDE ACETATE 100 MG | Marketed |
| 02534800 | FLECAINIDE | SANIS HEALTH INC | Tablet | FLECAINIDE ACETATE 50 MG | Marketed |
| 02493705 | JAMP FLECAINIDE | JAMP PHARMA CORPORATION | Tablet | FLECAINIDE ACETATE 50 MG | Marketed |
| 02493713 | JAMP FLECAINIDE | JAMP PHARMA CORPORATION | Tablet | FLECAINIDE ACETATE 100 MG | Marketed |
| 02476185 | MAR-FLECAINIDE | MARCAN PHARMACEUTICALS INC | Tablet | FLECAINIDE ACETATE 100 MG | Dormant |
| 02476177 | MAR-FLECAINIDE | MARCAN PHARMACEUTICALS INC | Tablet | FLECAINIDE ACETATE 50 MG | Dormant |
| 02530066 | NRA-FLECAINIDE | NORA PHARMA INC | Tablet | FLECAINIDE ACETATE 50 MG | Cancelled Post Market |
| 02530074 | NRA-FLECAINIDE | NORA PHARMA INC | Tablet | FLECAINIDE ACETATE 100 MG | Cancelled Post Market |
| 01966197 | TAMBOCOR | BAUSCH HEALTH, CANADA INC. | Tablet | FLECAINIDE ACETATE 50 MG | Dormant |
| 01966200 | TAMBOCOR | BAUSCH HEALTH, CANADA INC. | Tablet | FLECAINIDE ACETATE 100 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20028 | 2017-11-09 | Abbreviated New Drug Submission (ANDS) | Labelling Assessment and Administrative: Transfer of Drug Identification Number(s) |
| 11473 | 2010-06-02 | Abbreviated New Drug Submission (ANDS) | Manufacturer and product name change |
| 7713 | 2006-01-27 | Abbreviated New Drug Submission (ANDS) |
International API supply for FLECAINIDE ACETATE
8 valid EDQM Certificates of Suitability from 8 holders. 10 active FDA Drug Master Files.
Request a quote for APO-FLECAINIDE